Clinical and economic implications of epilepsy management across treatment lines in Spain: a real-life database analysis.

ABSTRACT:

Background

Epilepsy is a chronic brain disease characterized by recurrent seizures. We investigated real-world management of epilepsy across treatment lines in Spain, including healthcare resource use (HRU) and associated costs.

Methods

This was a retrospective study of real-life data from epilepsy patients prescribed antiseizure medication (ASM) between January 2016 and December 2021. Patients were grouped according to their line of treatment (1st, 2nd, 3rd and 4th +) during the recruitment period. Demographic and clinical characteristics, comorbidities and concomitant medications were analyzed during the baseline period (6 months before starting treatment line); antiepileptic treatments, concomitant medications, HRU and associated costs were analyzed during follow-up.

R

SUBMITTER: Toledano R 

PROVIDER: S-EPMC10632298 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature